Published in Cancer Weekly, March 4th, 2003
"cDNA array technology allows simultaneous analysis of relative expression levels of a broad spectrum of genes in two related cell populations. We used this technology with the aim of identifying markers specific for tumor ECs (TECs)," wrote M.C. Schmid and colleagues, University of Bern.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.